<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONSOLIDATED BALANCE SHEET AND CONSOLIDATED STATEMENT OF OPERATIONS OF ADVANCED VIRAL RESEARCH CORP. FOR THE SIX MONTHS ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> DEC-31-1999 <PERIOD-START> JAN-01-2000 <PERIOD-END> JUN-30-2000 <CASH> 2,571,008 <SECURITIES> 0 <RECEIVABLES> 0 <ALLOWANCES> 0 <INVENTORY> 19,729 <CURRENT-ASSETS> 2,710,391 <PP&E> 1,704,922<F1> <DEPRECIATION> 0 <TOTAL-ASSETS> 5,009,675 <CURRENT-LIABILITIES> 620,088 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 3,608 <OTHER-SE> 0 <TOTAL-LIABILITY-AND-EQUITY> 5,009,675 <SALES> 4,961 <TOTAL-REVENUES> 4,961 <CGS> 0 <TOTAL-COSTS> 0 <OTHER-EXPENSES> 2,792,896 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 677,504 <INCOME-PRETAX> (3,390,848) <INCOME-TAX> 0 <INCOME-CONTINUING> 0 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (3,390,848) <EPS-BASIC> (0.00) <EPS-DILUTED> (0.00) <FN> <F1>PP&E VALUES REPRESENT NET AMOUNTS </FN>